메뉴 건너뛰기




Volumn 26, Issue 10, 2011, Pages 2698-2708

Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: A randomized, double-blind Phase III trial

Author keywords

Dienogest; estradiol valerate; heavy and or prolonged menstrual bleeding; oral contraceptive; RCT

Indexed keywords

DIENOGEST PLUS ESTRADIOL VALERATE; FERRITIN; HEMOGLOBIN; ORAL CONTRACEPTIVE AGENT; PLACEBO; QLAIRA; UNCLASSIFIED DRUG;

EID: 79960741444     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der224     Document Type: Article
Times cited : (78)

References (29)
  • 1
    • 67749102907 scopus 로고    scopus 로고
    • Bleeding pattern and cycle control with an estradiol-based oral contraceptive: A seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel
    • Ahrendt H-J, Makalova D, Parke S, Mellinger U, Mansour D. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel. Contraception 2009; 80:436-444.
    • (2009) Contraception , vol.80 , pp. 436-444
    • Ahrendt, H.-J.1    Makalova, D.2    Parke, S.3    Mellinger, U.4    Mansour, D.5
  • 2
    • 68049083517 scopus 로고    scopus 로고
    • A Canadian multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia
    • Endrikat J, Shapiro H, Lukkari-Lax E, Kunz M, Schmidt W, Fortier M. A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia. J Obstet Gynaecol Can 2009; 31:340-347.
    • (2009) J Obstet Gynaecol Can , vol.31 , pp. 340-347
    • Endrikat, J.1    Shapiro, H.2    Lukkari-Lax, E.3    Kunz, M.4    Schmidt, W.5    Fortier, M.6
  • 3
    • 0026022033 scopus 로고
    • Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia
    • Fraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust N Z J Obstet Gynaecol 1991;31:66-70.
    • (1991) Aust N Z J Obstet Gynaecol , vol.31 , pp. 66-70
    • Fraser, I.S.1    McCarron, G.2
  • 4
    • 77951751217 scopus 로고    scopus 로고
    • Health-related quality of life and economic burden of abnormal uterine bleeding
    • Fraser IS, Langham S, Uhl-Hochgraeber K. Health-related quality of life and economic burden of abnormal uterine bleeding. Expert Rev Obstet Gynecol 2009;4:179-189.
    • (2009) Expert Rev Obstet Gynecol , vol.4 , pp. 179-189
    • Fraser, I.S.1    Langham, S.2    Uhl-Hochgraeber, K.3
  • 5
    • 79960721784 scopus 로고    scopus 로고
    • Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: Pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of estradiol valerate and dienogest
    • Fraser IS, Parke S, Mellinger U, Machlitt A, Serrani M, Jensen J. Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of estradiol valerate and dienogest. Eur J Contracept Reprod Health Care 2011;16:258-269.
    • (2011) Eur J Contracept Reprod Health Care , vol.16 , pp. 258-269
    • Fraser, I.S.1    Parke, S.2    Mellinger, U.3    MacHlitt, A.4    Serrani, M.5    Jensen, J.6
  • 7
    • 0014003038 scopus 로고
    • Menstrual blood loss - A population study Variation at different ages and attempts to define normality
    • Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss-a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966;45:320-351.
    • (1966) Acta Obstet Gynecol Scand , vol.45 , pp. 320-351
    • Hallberg, L.1    Hogdahl, A.M.2    Nilsson, L.3    Rybo, G.4
  • 9
    • 36549074502 scopus 로고    scopus 로고
    • Current treatment options for abnormal uterine bleeding: An evidence-based approach
    • DOI 10.1016/j.bpobgyn.2007.03.021, PII S1521693407000788, Conservative Surgery for Abnormal Uterine Bleeding
    • Istre O, Qvigstad E. Current treatment options for abnormal uterine bleeding: an evidence-based approach. Best Pract Res Clin Obstet Gynaecol 2007;21:905-913. (Pubitemid 350177606)
    • (2007) Best Practice and Research in Clinical Obstetrics and Gynaecology , vol.21 , Issue.6 , pp. 905-913
    • Istre, O.1    Qvigstad, E.2
  • 10
    • 77951264748 scopus 로고    scopus 로고
    • A multicenter, double-blind, randomized, placebo-controlled study of oral estradiol valerate/dienogest for the treatment of heavy and/or prolonged menstrual bleeding
    • Jensen J, Machlitt A, Mellinger U, Schaefers M, Fraser IS. A multicenter, double-blind, randomized, placebo-controlled study of oral estradiol valerate/dienogest for the treatment of heavy and/or prolonged menstrual bleeding. Fertil Steril 2009;92:S32.
    • (2009) Fertil Steril , vol.92
    • Jensen, J.1    MacHlitt, A.2    Mellinger, U.3    Schaefers, M.4    Fraser, I.S.5
  • 11
    • 77957253254 scopus 로고    scopus 로고
    • Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: A randomized controlled trial
    • Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, Muysers C, Jensen JT. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 2010;116:625-632.
    • (2010) Obstet Gynecol , vol.116 , pp. 625-632
    • Kaunitz, A.M.1    Bissonnette, F.2    Monteiro, I.3    Lukkari-Lax, E.4    Muysers, C.5    Jensen, J.T.6
  • 12
    • 0345277915 scopus 로고    scopus 로고
    • Efficacy and tolerability of a combined oral contraceptive containing 17 b-estradiol and desogestrel
    • Kivinen S, Saure A. Efficacy and tolerability of a combined oral contraceptive containing 17 b-estradiol and desogestrel. Eur J Contracept Reprod Health Care 1996;1:183.
    • (1996) Eur J Contracept Reprod Health Care , vol.1 , pp. 183
    • Kivinen, S.1    Saure, A.2
  • 13
    • 0018820995 scopus 로고
    • A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens
    • Koetsawang S, Mandlekar AV, Krishna UR, Purandare VN, Deshpande CK, Chew SC, Fong R, Ratnam SS, Kovacs L, Zalanyi S et al. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception. Contraception 1980; 21:445-459. (Pubitemid 10068906)
    • (1980) Contraception , vol.21 , Issue.5 , pp. 445-459
    • Koetsawang, S.1    Mandlekar, A.V.2    Chew, S.C.3
  • 14
    • 0026806578 scopus 로고
    • The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status
    • Larsson G, Milsom I, Lindstedt G, Rybo G. The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status. Contraception 1992;46:327-334.
    • (1992) Contraception , vol.46 , pp. 327-334
    • Larsson, G.1    Milsom, I.2    Lindstedt, G.3    Rybo, G.4
  • 15
    • 0036169009 scopus 로고    scopus 로고
    • Mechanisms of abnormal uterine bleeding
    • DOI 10.1093/humupd/8.1.60
    • Livingstone M, Fraser IS. Mechanisms of abnormal uterine bleeding. Hum Reprod Update 2002;8:60-67. (Pubitemid 34144986)
    • (2002) Human Reproduction Update , vol.8 , Issue.1 , pp. 60-67
    • Livingstone, M.1    Fraser, I.S.2
  • 17
    • 0031716662 scopus 로고    scopus 로고
    • Iron status in 268 Danish women aged 18-30 years: Influence of menstruation, contraceptive method, and iron supplementation
    • DOI 10.1007/s002770050405
    • Milman N, Clausen J, Byg KE. Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation. Ann Hematol 1998;77:13-19. (Pubitemid 28425169)
    • (1998) Annals of Hematology , vol.77 , Issue.1-2 , pp. 13-19
    • Milman, N.1    Clausen, J.2    Byg, K.-E.3
  • 21
    • 76049130557 scopus 로고    scopus 로고
    • Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A Phase III trial
    • Palacios S, Wildt L, Parke S, Machlitt A, Romer T, Bitzer J. Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial. Eur J Obstet Gynecol Reprod Biol 2010;149:57-62.
    • (2010) Eur J Obstet Gynecol Reprod Biol , vol.149 , pp. 57-62
    • Palacios, S.1    Wildt, L.2    Parke, S.3    MacHlitt, A.4    Romer, T.5    Bitzer, J.6
  • 22
    • 24344491969 scopus 로고    scopus 로고
    • Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: A multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts
    • DOI 10.1111/j.1471-0528.2005.00642.x
    • Reid PC, Virtanen-Kari S. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. BJOG 2005;112:1121-1125. (Pubitemid 41632669)
    • (2005) BJOG: An International Journal of Obstetrics and Gynaecology , vol.112 , Issue.8 , pp. 1121-1125
    • Reid, P.C.1    Virtanen-Kari, S.2
  • 23
    • 37649011457 scopus 로고    scopus 로고
    • Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile
    • Sasagawa S, Shimizu Y, Kami H, Takeuchi T, Mita S, Imada K, Kato S, Mizuguchi K. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids 2008; 73:222-231.
    • (2008) Steroids , vol.73 , pp. 222-231
    • Sasagawa, S.1    Shimizu, Y.2    Kami, H.3    Takeuchi, T.4    Mita, S.5    Imada, K.6    Kato, S.7    Mizuguchi, K.8
  • 24
    • 78650735049 scopus 로고    scopus 로고
    • A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia
    • Sayed GH, Zakherah MS, El-Nashar SA, Shabaan MM. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia. Int J Gynaecol Obstet 2011;112:126-130.
    • (2011) Int J Gynaecol Obstet , vol.112 , pp. 126-130
    • Sayed, G.H.1    Zakherah, M.S.2    El-Nashar, S.A.3    Shabaan, M.M.4
  • 25
    • 0023544567 scopus 로고
    • Ovulation inhibition with 17β-estradiol cyclo-octyl acetate and desogestrel
    • Schubert W, Cullberg G. Ovulation inhibition with 17 beta-estradiol cyclo-octyl acetate and desogestrel. Acta Obstet Gynecol Scand 1987;66:543-547. (Pubitemid 18014725)
    • (1987) Acta Obstetricia et Gynecologica Scandinavica , vol.66 , Issue.6 , pp. 543-547
    • Schubert, W.1    Cullberg, G.2
  • 26
    • 0018290751 scopus 로고
    • Natural oestrogens for oral contraception
    • Serup J, Bostofte E, Larsen S, Westergaard J, Lebech PE. Natural oestrogens for oral contraception. Lancet 1979;2:471-472. (Pubitemid 9250419)
    • (1979) Lancet , vol.2 , Issue.8140 , pp. 471-472
    • Serup, J.1    Bostofte, E.2    Larsen, S.3
  • 27
    • 78649907686 scopus 로고    scopus 로고
    • Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: A randomized clinical trial
    • Shabaan MM, Zakherah MS, El-Nashar SA, Sayed GA. Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial. Contraception 2011;83:48-54.
    • (2011) Contraception , vol.83 , pp. 48-54
    • Shabaan, M.M.1    Zakherah, M.S.2    El-Nashar, S.A.3    Sayed, G.A.4
  • 28
    • 0015348046 scopus 로고
    • Quantitation of menstrual blood loss-further evaluation of the alkaline hematin method
    • Shaw ST Jr, Aaronson DE, Moyer DL. Quantitation of menstrual blood loss-further evaluation of the alkaline hematin method. Contraception 1972;5:497-513.
    • (1972) Contraception , vol.5 , pp. 497-513
    • Shaw Jr., S.T.1    Aaronson, D.E.2    Moyer, D.L.3
  • 29
    • 0027381532 scopus 로고
    • Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17β-estradiol
    • Wenzl R, Bennink HC, van Beek A, Spona J, Huber J. Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol. Fertil Steril 1993;60:616-619. (Pubitemid 23298503)
    • (1993) Fertility and Sterility , vol.60 , Issue.4 , pp. 616-619
    • Wenzl, R.1    Bennink, H.C.2    Van Beek, A.3    Spona, J.4    Huber, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.